| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/21/2004 | EP1381614A2 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO 2,3-f]QUINOXALINE |
| 01/21/2004 | EP1381613A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused- 1,4]-benzodioxans |
| 01/21/2004 | EP1381611A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 01/21/2004 | EP1381608A1 Cyclohexylphenyl vasopressin agonists |
| 01/21/2004 | EP1381607A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepine-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 01/21/2004 | EP1381606A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 01/21/2004 | EP1381605A1 Mercaptoacetylamide derivatives, a process for their preparation and their use |
| 01/21/2004 | EP1381604A2 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 01/21/2004 | EP1381603A2 Quinuclidine-substituedaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands ) |
| 01/21/2004 | EP1381602A1 Heterocyclyldicarbamides as caspase inhibitors |
| 01/21/2004 | EP1381601A1 Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same |
| 01/21/2004 | EP1381599A1 Quinazoline derivatives |
| 01/21/2004 | EP1381598A1 Novel tyrosine kinase inhibitors |
| 01/21/2004 | EP1381594A1 Urea compounds useful as anti-inflammatory agents |
| 01/21/2004 | EP1381592A1 1,4-disubstituted benzo-fused compounds |
| 01/21/2004 | EP1381591A2 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP1381587A1 Glycerol-peg-derivatives as inhibitors of cyclooxygenase-2 and phospholipase-a2 |
| 01/21/2004 | EP1381431A1 Aromatase inhibition to enhance assisted reproduction |
| 01/21/2004 | EP1381408A2 Modular infusion device and method |
| 01/21/2004 | EP1381397A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 01/21/2004 | EP1381392A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 01/21/2004 | EP1381382A2 Methods and compositions for the treatment of diseases of the eye |
| 01/21/2004 | EP1381379A1 Hop extracts and use thereof in the production of a medicament having estrogenic properties |
| 01/21/2004 | EP1381378A1 Compositions and methods for cancer prevention and treatment derived from inula britannica |
| 01/21/2004 | EP1381377A2 A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade |
| 01/21/2004 | EP1381376A2 In vivo use of water absorbent polymers |
| 01/21/2004 | EP1381375A2 Oligonucleotide compositions and their use to induce differentiation of cells |
| 01/21/2004 | EP1381374A1 Veterinary compositions comprising avermectin-oxime derivatives and praziquantel |
| 01/21/2004 | EP1381373A1 A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method |
| 01/21/2004 | EP1381372A2 Substituted tetracycline compounds as synergistic antifungal agents |
| 01/21/2004 | EP1381371A2 Hormone replacement therapy |
| 01/21/2004 | EP1381370A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists |
| 01/21/2004 | EP1381369A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence |
| 01/21/2004 | EP1381368A2 Compositions containing imidazotriazinone for nasal application |
| 01/21/2004 | EP1381367A1 Aripiprazole oral solution |
| 01/21/2004 | EP1381366A2 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 01/21/2004 | EP1381365A1 Pyrrolidine sulfonamides |
| 01/21/2004 | EP1381364A1 Use of mangafodipir for treating oxidative stress effects |
| 01/21/2004 | EP1381363A1 Imidazo [1,2-a]-pyridine derivatives as mglur5 antagonists |
| 01/21/2004 | EP1381362A2 Pharmaceutical composition comprising clavulanic acid |
| 01/21/2004 | EP1381361A1 Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| 01/21/2004 | EP1381360A1 Compounds and methods for inhibiting metap2 in mammals |
| 01/21/2004 | EP1381359A1 Aurones as telomerase inhibitors |
| 01/21/2004 | EP1381358A1 Solid pharmaceutical composition comprising 4'-cyano-trifluoro-3-(4-fluorophenylsulphonyl) -2-hydroxy-2-methylpropiono- m toluidide and pvp |
| 01/21/2004 | EP1381357A2 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 01/21/2004 | EP1381356A1 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| 01/21/2004 | EP1381355A2 Matrix metalloproteinase inhibitors |
| 01/21/2004 | EP1381354A2 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
| 01/21/2004 | EP1381353A2 Ipratropium formulation for pulmonary inhalation |
| 01/21/2004 | EP1381352A1 Transdermal patch for administering fentanyl |
| 01/21/2004 | EP1381348A1 Skin-protective compositions effective against vesicants and percutaneous chemical agents |
| 01/21/2004 | EP1381346A2 Aerosol compositions containing formoterol for delivery to the lungs via nebulization |
| 01/21/2004 | EP1381311A2 Methods and reagents to acquire mri signals and images |
| 01/21/2004 | EP1381276A2 Method of treating or retarding the development of blindness |
| 01/21/2004 | EP1313749A4 Process for preparation of anhydrous azithromycin |
| 01/21/2004 | EP1305028A4 Antimicrobial biaryl compounds |
| 01/21/2004 | EP1280799B1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/21/2004 | EP1257265B1 Use of 2-phenylene diamine derivatives for the treatment of infections |
| 01/21/2004 | EP1242415B1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 01/21/2004 | EP1229802A4 Food product and process for manufacturing same |
| 01/21/2004 | EP1229791B1 Active ingredient combination having insecticidal and acaricidal characteristics |
| 01/21/2004 | EP1191942B1 Use of antileukoprotease for the treatment of endometriosis |
| 01/21/2004 | EP1165025B1 Compact hairspray product consisting of hairspray concentrate, container and fine spray pump with pre-pressurization |
| 01/21/2004 | EP1150660B1 Pharmaceutical effervescent formulation containing metamizol |
| 01/21/2004 | EP1128826B1 Chromone enteric release formulation |
| 01/21/2004 | EP1126852B1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 01/21/2004 | EP1019048B1 Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
| 01/21/2004 | EP0999846B1 Phosphatidic acid-based immune modulator composition |
| 01/21/2004 | EP0981366B1 Selective mmp inhibitors having reduced side-effects |
| 01/21/2004 | EP0948491B1 Aminothiazole derivatives useful in the preparation of beta-lactam antibiotics |
| 01/21/2004 | EP0942723B1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 01/21/2004 | EP0937048B1 HETEROCYCLE DERIVATIVES WHICH INHIBIT FACTOR Xa |
| 01/21/2004 | EP0935463B1 Use of anti-neurogenic inflammatory compounds and compositions |
| 01/21/2004 | EP0914165A4 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| 01/21/2004 | EP0914124B1 ANTITHROMBOTIC AND ANTIATHEROGENIC PHARMACEUTICAL COMPOSITION INCLUDING A THIENOPYRIDINE DERIVATIVE AND AN HMG-CoA-REDUCTASE INHIBITOR |
| 01/21/2004 | EP0912177B1 Use of flupirtine for therapy and prophylaxis of myocardial infarction, shock kidney and shock lung |
| 01/21/2004 | EP0853627B1 Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| 01/21/2004 | EP0811002B1 Benzylpiperidines and piperazines as muscarinic antagonists |
| 01/21/2004 | EP0752871B1 Adhesion inhibiting vaccinium extract |
| 01/21/2004 | EP0727998B1 Oxazoles for treating cytokine mediated diseases |
| 01/21/2004 | CN1469926A Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/21/2004 | CN1469880A Pharmaceutical compositions |
| 01/21/2004 | CN1469879A Substituted 3,4-dihydro-pyrimido[1,2-A] pyrimidines and 3,4-dihydropyrazino [1,2-A] pyrimidines |
| 01/21/2004 | CN1469878A Aza-and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| 01/21/2004 | CN1469877A Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
| 01/21/2004 | CN1469876A Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469873A Piperidine compounds as anti-allergic |
| 01/21/2004 | CN1469872A A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride |
| 01/21/2004 | CN1469868A Use of triazinetrione sulfones for combating coccidiosis |
| 01/21/2004 | CN1469866A New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication |
| 01/21/2004 | CN1469865A Pyrazole derivatives for the treatment of viral diseases |
| 01/21/2004 | CN1469864A Process for preparing cilostazol |
| 01/21/2004 | CN1469863A Crystal form of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl] piperazine hydrochloride |
| 01/21/2004 | CN1469860A Aza-amino acid derivatives (factor XA-inhibitors 15) |
| 01/21/2004 | CN1469858A Aspirin-triggered lipid mediators |
| 01/21/2004 | CN1469759A Implants with a phosphazene-containing coating |
| 01/21/2004 | CN1469755A Vaccines containing ribavirin and methods of use thereof |